A team of Chinese scientists has used targeted gene editing to develop rice that produces coenzyme Q10 (CoQ10), a vital ...

No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception. This is because biology is by far the most “messy” of hard sciences. Chemistry or physics can deal ...

Biotech stocks are companies that use living organisms to make drugs and vaccines. Often, they merge cutting-edge technology with new findings in molecular science and virology to treat life ...

Check out the latest biotech industry news, from hydrogels supporting patient-derived xenograft studies and NGS panels capable of detecting MRD, to a generative AI platform for biology and chemistry ...

White House Press Secretary Karoline Leavitt answered questions about the Trump administration’s decision to suspend federal aid to several assistance programs. Photo: Roberto Schmidt/AFP/Getty ...

Now, a little more than a year later, she’s making cuts of her own. The neuro-focused biotech is “making changes” to its research team to “reinvigorate the company's drug discovery ...

In November, the president had said Doge would advise White House officials from outside ... from fast-tracked clearance and will avoid FBI background checks for criminal histories and other ...

Over a black background below that, white lettering reads “Department ... Those include one with a DOGE logo featuring a cheerful cartoon dog with an American flag, and another with the image ...

They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...

A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...

ArriVent Biopharma, a company that secures rights to drugs from emerging markets to develop them for Western markets, is adding to its pipeline with a Phase 1-ready drug candidate from China that ...